Leerink Partnrs Cuts Earnings Estimates for agilon health

agilon health, inc. (NYSE:AGL) – Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for shares of agilon health in a research note issued to investors on Tuesday, February 25th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn ($0.03) per share for the quarter, down from their prior forecast of $0.05. The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. Leerink Partnrs also issued estimates for agilon health’s Q2 2025 earnings at ($0.09) EPS, Q3 2025 earnings at ($0.13) EPS, Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($0.36) EPS, Q1 2026 earnings at ($0.01) EPS, Q2 2026 earnings at ($0.01) EPS, Q3 2026 earnings at ($0.12) EPS, Q4 2026 earnings at ($0.10) EPS, FY2026 earnings at ($0.23) EPS, FY2027 earnings at ($0.15) EPS, FY2028 earnings at $0.00 EPS and FY2029 earnings at $0.12 EPS.

AGL has been the subject of a number of other reports. Barclays decreased their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Sanford C. Bernstein upped their price objective on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Royal Bank of Canada upped their price objective on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research note on Wednesday. Finally, Macquarie began coverage on agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective for the company. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $3.95.

agilon health Stock Down 6.9 %

Shares of NYSE AGL opened at $3.12 on Friday. The stock has a market cap of $1.29 billion, a PE ratio of -3.32 and a beta of 0.66. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 52-week low of $1.50 and a 52-week high of $7.73. The business has a 50-day moving average price of $2.96 and a 200 day moving average price of $3.03.

Insider Transactions at agilon health

In other news, Director Karen Mcloughlin purchased 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The shares were acquired at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John William Wulf purchased 45,000 shares of the stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders acquired 77,500 shares of company stock valued at $169,600. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Large investors have recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. acquired a new stake in agilon health during the 3rd quarter valued at $28,000. Oak Thistle LLC acquired a new stake in agilon health during the 4th quarter valued at $25,000. Ieq Capital LLC acquired a new stake in agilon health during the 4th quarter valued at $26,000. Signaturefd LLC grew its holdings in agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after buying an additional 8,467 shares during the last quarter. Finally, Humankind Investments LLC acquired a new stake in agilon health during the 4th quarter valued at $30,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.